Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 09/20/202
-
Total 13F shares
-
3,482,173
-
Share change
-
-784,628
-
Total reported value
-
$728,965
-
Price per share
-
$0.20
-
Number of holders
-
32
-
Value change
-
-$167,049
-
Number of buys
-
3
-
Number of sells
-
8
Institutional Holders of American Oncology Network, Inc. - *W EXP 09/20/202 (AONCW) as of Q4 2023
As of 31 Dec 2023,
American Oncology Network, Inc. - *W EXP 09/20/202 (AONCW) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,482,173 shares.
The largest 10 holders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, Shaolin Capital Management LLC, D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, SECURITY BENEFIT LIFE INSURANCE CO /KS/, Calamos Advisors LLC, Sculptor Capital LP, DAVIDSON KEMPNER CAPITAL MANAGEMENT LP, CANTOR FITZGERALD, L. P., and Walleye Capital LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.